Woodbridge Closes Arkansas Cancer-Alliance Oncology Deal
July 27, 2010
New Haven, Connecticut – July 27, 2010 – Woodbridge,
a leading middle-market mergers and acquisitions firm, is pleased to announce the acquisition of Arkansas Cancer Institute’s (ACI) Radiation Oncology unit by Alliance Oncology, a division of Alliance HealthCare Services, based in Newport Beach, California.
ACI’s Radiation Oncology department offers state-of-the-art cancer treatments such as Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy, as well as diagnostic services such as CT scan and PET.
Alliance HealthCare Services, a public company listed on the New York Stock Exchange, is the nation’s largest provider of advanced outpatient diagnostic imaging services, focusing on MRI, PET/CT and CT through its Alliance Imaging division and delivering radiation therapy services through its Alliance Oncology division.
The Arkansas Cancer Institute-Alliance HealthCare transaction was managed by Woodbridge dealmaker Tex Sekhon, who is based in the firm’s Dallas-area office.
“We are proud to have negotiated a financially attractive transaction for our client — and one that ensures the residents of south central Arkansas will continue to receive advanced diagnostic imaging and radiation therapy services for years to come,” said Mr. Sekhon.
In a recent announcement, Paul S. Viviano, chairman of the board and CEO of Alliance HealthCare Services, said, “With a reputation for the highest levels of clinical care and patient satisfaction, the addition of this facility will play an important role in the continued growth of Alliance Oncology.”
Woodbridge, LLC., an international M&A firm, was founded in 1993 to provide divestiture and acquisition services to middle market companies.